Does LURBINECTEDIN Cause Disease progression? 98 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Disease progression have been filed in association with LURBINECTEDIN (ZEPZELCA). This represents 10.1% of all adverse event reports for LURBINECTEDIN.
98
Reports of Disease progression with LURBINECTEDIN
10.1%
of all LURBINECTEDIN reports
28
Deaths
14
Hospitalizations
How Dangerous Is Disease progression From LURBINECTEDIN?
Of the 98 reports, 28 (28.6%) resulted in death, 14 (14.3%) required hospitalization, and 2 (2.0%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for LURBINECTEDIN.
What Other Side Effects Does LURBINECTEDIN Cause?
Death (129)
Off label use (69)
Neutropenia (59)
Nausea (58)
Thrombocytopenia (48)
Fatigue (43)
Febrile neutropenia (39)
Vomiting (37)
Asthenia (36)
Anaemia (34)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which LURBINECTEDIN Alternatives Have Lower Disease progression Risk?
LURBINECTEDIN vs LUSPATERCEPT
LURBINECTEDIN vs LUSPATERCEPT-AAMT
LURBINECTEDIN vs LUTEIN
LURBINECTEDIN vs LUTETIUM LU-177
LURBINECTEDIN vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN